Lung tumorspheres as a drug screening platform against cancer stem cells von Herreros Pomares, A., Amado, H., Calabuig Fariñas, S., Escorihuela, E., Murga, J., Torres, S., Durendez-Saez, E., Zhang, F., Blasco, A., Navarro, A., Sampedro, C., Jantus-Lewintre, E., Camps, C.

Volltext

Applicability of ctDNA at diagnosis and during the monitoring of EGFR-mutated patients von Calabuig Fariñas, S., Blasco, A., Durendez-Saez, E., Fernández, A., Mosqueda, M., Escorihuela, E., Herreros Pomares, A., Aparisi, F., Garde, J., Shahin, M., Jantus-Lewintre, E., Camps, C.

Volltext

Clinical impact of using a deep genomic profile in carcinoma of unknown origin von Fernandez Díaz, A., Iranzo, V., Calabuig Fariñas, S., Jantus, E., Cunquero Tomas, A.J., Avila Andrade, C., Sauvage, S., Beniuga, G., Camps, C.J.

Volltext

Interactions of cancer stem cell and immune microenvironment in non-small cell lung cancer (NSCLC) von Zhang, F., Dong, N., Torres, S., Calabuig Fariñas, S., Sirera Perez, R., Mosqueda, M., Escorihuela, E., Jantus-Lewintre, E., Camps, C.

Volltext

Exosomes in NSCLC: Analysis of its cargo as a source of biomarkers von Durendez-Saez, E., Calabuig Fariñas, S., Suarez, C., Mosqueda, M., Gallach, S., Escorihuela, E., Moreno, A., Dong, N., Herreros Pomares, A., de la Cueva, E., Martinez-Romero, A., Serna, E., Paramio, J.M., Jantus-Lewintre, E., Camps, C.

Volltext

An expression signature characterizes cancer stem cells from lung adenocarcinoma patients von Herreros-Pomares, A., Calabuig Fariñas, S., de Maya, J.D., Escorihuela, E., Durendez-Saez, E., Blasco Cordellat, A., Navarro, A., García-Del-Olmo, E., Lucas, R., Farràs, R., Jantus-Lewintre, E., Camps, C.

Volltext

High-throughput screening of new drugs targeting lung CSCs von Amado Labrador, H.A., Jantus-Lewintre, E., Calabuig Fariñas, S., Aguilar-Gallardo, C., Murga, J., Munera-Maravilla, E., Durendez-Saez, E., Mosqueda, M., Escorihuela, E., Zhang, F., Masiá, E., Dong, N., Guijarro, R., Camps, C.

Volltext

CD5 and CD6: Evaluation of their role as prognostic biomarkers in resectable non-small cell lung cancer von Moreno, A., Calabuig Fariñas, S., Gallach Garcia, S., Fernando, A., Simoes, I., Carreras, E., Consuegra-Fernández, M., Blasco Cordellat, A., Cunquero Tomas, A.J., Martorell, M., Camps, C., Lozano, F., Sirera Perez, R., Jantus-Lewintre, E.

Volltext

66P PALB2 mRNA expression as a predictive marker in advanced non-small cell lung cancer (NSCLC) patients (p) treated with docetaxel-cisplatin von Karachaliou, N., Berenguer, J., Chaib, I., Serrano, J.L. Ramírez, Bueno, M.T. Moran, Sureda, B. Massuti, Farinas, S. Calabuig, Camps, C., Pulla, M. Provencio, Rosell, R.

Volltext

Soluble immune biomarkers to anti-PD1 treatment in non-small cell lung cancer (NSCLC) von Garde-Noguera, J., Jantus-Lewintre, E., Honrubia Peris, B., Gallach Garcia, S., Zhang, F., García Sánchez, J., Calabuig Fariñas, S., Blasco Cordellat, A., Piera Molons, N., Vidal-Martinez, J., Murado-Pardo, J., Condori Farfan, L.D., Gisbert-Criado, R., Escorihuela, E., Camps, C.

Volltext

Carcinoma of unknown origin: Deep genomic profile helps to achieve an accurate diagnosis von Fernandez Díaz, A.B., Iranzo Gonzalez-Cruz, V., Cunquero Tomas, A.J., Avila Andrade, C., Jantus-Lewintre, E., Calabuig Fariñas, S., Ales, J.E., Valero, M., D'Errico, G., Pazo Cid, R.A., Gallego Martínez, A., Viana, A., Ponce Aix, S., Pérez-Fidalgo, J.A., Terradez, A., Rodrigo, A., Alvarez, L., Beniuga, G., Martorell, M., Camps, C.

Volltext

133 Analysis of immune microenvironment in resectable NSCLC: Prognostic value of regulatory and conventional T cell markers proportion von Uso, M, Sirera, R, Calabuig-Fariñas, S, Blasco, A, Pastor, E, Guijarro, R, Jantus-Lewintre, E, Forteza, J, Camps, C

Volltext

122 Analysis of immune-response markers in resectable NSCLC von Usó, M, Jantus-Lewintre, E, Sirera, R, Calabuig-Fariñas, S, Gallach, S, Escorihuela, E, Blasco, A, Guijarro, R, Camps, C

Volltext

665: Cullin-RING ligases inhibition is a potential new therapeutic strategy in soft tissue sarcomas von Martín, A, Felipe-Abrio, I, Obrador-Hevia, A, Calabuig-Fariñas, S, Alemany, R, Martín, J

Volltext

661: Wnt/β-catenin signalling inhibition decreases cell proliferation in Wnt autocrine-soft tissue sarcoma cells von Obrador-Hevia, A, Calabuig-Fariñas, S, Martínez, E, Ochoa, A, Felipe-Abrio, I, Martín, J, Alemany, R

Volltext

149P The role of CTCs and cfDNA for diagnosis and monitoring of EGFR mutations in advanced NSCLC patients von Calabuig-Fariñas, S., Lewintre, E. Jantus, Mayo-De-Las-Casas, C., Cordellat, A. Blasco, Molina-Vila, M.A., Rosell, R., Camps, C.

Volltext

62P Novel therapeutic strategies in NSCLC: Lung-tumorspheres as an effective in vitro screening platform von Maravilla, E. Munera, Pomares, A. Herreros, Calabuig-Fariñas, S., Lewintre, E. Jantus, Lucas, R., Guijarro, R., Madriaga, A.I. Martinez, Cordellat, A. Blasco, Camps, C.

Volltext

114P Expression analysis of tumorspheres from non-small cell lung cancer show significant differences in CSC-markers and signaling pathways von Pomares, A. Herreros, Maravilla, E. Munera, Lafuente, B., Calabuig-Fariñas, S., Cordellat, A. Blasco, Guijarro, R., Farrás, R., Lewintre, E. Jantus, Camps, C.

Volltext

545 MiRNAs related to KRAS mutational status in resectable non-small cell lung cancer von Gallach, S, Calabuig-Fariñas, S, Jantus-Lewintre, E, Montaner, D, Escorihuela, E, Castellano, J, Figueroa, S, Blasco, A, Hernando, C, Guijarro, R, Camps, C

Volltext

Prognostic and Predictive Non-Invasive Biomarkers in Cutaneous Melanoma Treated With Anti PD-1 Antibodies von Torres-Martínez, S., Fernández, A., Carbonell, J., Escorihuela, E., Juciute, N., Ramos, I., Berrocal, A., Jantus-Lewintre, E., Camps, C., Calabuig-Fariñas, S.

Volltext